17 Nov 2025 | 5 Mins Read
Alembic's stock rises with USFDA approval for hypertension medication
Flipitmoney
Shares of Alembic Pharmaceuticals are likely to be in focus on Monday. Alembic Pharmaceuticals received US FDA approval for Diltiazem Hydrochloride Tablets USP in 4 strengths, treating high blood pressure and angina. This is the company's 210th final approval from the USFDA, making its cumulative total of 230 ANDA approvals, including 20 tentative approvals.